dpp 4 inhibitors glp 1 GLP-1 Receptor Agonists Have better Outcomes Than DPP4 in T2D patients & CKD Cardiovascular effects of DPP-4 inhibition:
Description
At the end of 2025 we saw Eli Lillys Phase 3 TRIUMPH-4 trial for retatrutide read out
Background: Type 2 diabetes mellitus (T2D) is associated with an increased fracture risk
Sarah Mess.
these signals are hypothesis-generating only and do not establish causality or incidence
Metabolism & Energy: Formulated with ingredients that support metabolic processes and contribute to normal energy-yielding metabolism
